Self-Driving Car Accidents: Liability, Medication Access, and Pharmacy Liens

James Wong — Founder & Pharmacist, LienScripts | March 29, 2026 | 9 min read

Autonomous vehicle accidents create unprecedented liability disputes between vehicle manufacturers, software developers, and vehicle owners — and these disputes delay settlements far longer than conventional auto accident cases. For injured plaintiffs, the extended timeline makes pharmacy lien access to medications critical because traditional insurance and PIP benefits exhaust long before the liability questions resolve.

Autonomous vehicle (AV) accidents present a new category of personal injury case where liability disputes between vehicle manufacturers, software developers, sensor suppliers, and vehicle operators can extend case resolution to 3-5 years or longer — far exceeding the typical 12-18 month PI timeline. For injured plaintiffs, this extended timeline creates a medication access crisis that pharmacy liens are uniquely positioned to solve, because lien-funded prescriptions require no upfront payment and no liability determination before dispensing begins.

• AV accident cases involve multi-party liability disputes (manufacturer, software developer, sensor supplier, vehicle owner) that extend settlement timelines to 3-5+ years
• Traditional auto insurance PIP and MedPay benefits exhaust within months, leaving plaintiffs without medication coverage for years during the liability investigation
• Pharmacy liens provide continuous medication access throughout the extended dispute period because they are paid from the eventual settlement, not from current insurance
• LienScripts generates a MERIT (Medication Evaluation & Rationale for Injury Treatment) report for every case, providing pharmacist-signed documentation that tracks the full medication timeline — critical for cases that span years
• According to James Wong, PharmD, founder of LienScripts, "AV accident cases will be the longest-running PI cases most attorneys encounter. Continuous medication access over a 3-5 year period requires a funding mechanism that does not depend on current insurance — that is exactly what a pharmacy lien provides"

The Emerging Liability Landscape

As of 2026, autonomous vehicles from Waymo, Cruise (GM), Tesla (Full Self-Driving), Zoox (Amazon), and several other manufacturers are operating on public roads in expanding geographies. NHTSA has reported a growing number of AV-involved crashes, and the National Transportation Safety Board (NTSB) has investigated several fatal and serious-injury incidents.

The liability framework for AV accidents is fundamentally different from conventional auto accidents:

Products liability vs. negligence. In a conventional accident, liability is typically based on driver negligence. In an AV accident, the vehicle was driving itself — shifting the analysis to products liability against the manufacturer, software developer, or component supplier.

Multi-defendant complexity. A single AV accident can involve claims against the vehicle manufacturer (hardware defect), the software developer (algorithm failure), the sensor supplier (lidar or camera malfunction), the mapping data provider (incorrect road data), and the vehicle owner or operator (failure to maintain or override).

Federal preemption questions. The National Highway Traffic Safety Administration has issued guidance on AV safety but has not established a comprehensive federal regulatory framework. Whether federal AV regulations preempt state tort claims remains an open and evolving question.

[!KEY] The multi-defendant, multi-theory nature of AV accident litigation extends case timelines dramatically. Each defendant has its own counsel, its own expert witnesses, and its own discovery demands. Cases that would settle in 12-18 months as conventional auto accidents can take 3-5 years or longer when AV liability is in dispute.

The Medication Access Timeline Problem

In a conventional 12-18 month PI case, medication access is already a challenge. PIP benefits exhaust, health insurance disputes accident-related coverage, and patients face gaps in prescription access.

In a 3-5 year AV case, the problem is orders of magnitude worse:

• PIP exhaustion: In no-fault states, PIP benefits ($4,500 to $50,000 depending on the state) exhaust within the first 6-12 months
• MedPay exhaustion: MedPay coverage ($1,000 to $25,000 in most policies) exhausts even faster
• Health insurance disputes: Health insurers routinely deny accident-related claims during an extended liability investigation, arguing the auto insurer or manufacturer should pay
• Out-of-pocket impossibility: Patients recovering from serious AV accident injuries — which frequently involve traumatic brain injury, spinal cord damage, and multi-system trauma — cannot sustain out-of-pocket prescription costs for years

The result: without a pharmacy lien, AV accident plaintiffs face years without access to prescribed medications during the period when continuous treatment is most critical for recovery and case value.

How Pharmacy Liens Bridge the AV Liability Gap

A pharmacy lien functions as a bridge between the injury date and the eventual settlement or verdict. The pharmacy dispenses medications to the patient at zero out-of-pocket cost, and the lien is satisfied from the settlement proceeds when the case resolves — whether that takes 12 months or 5 years.

For AV accident cases specifically, the pharmacy lien provides:

1. Immediate activation: The lien can be activated at enrollment, before any liability determination. The patient begins receiving medications regardless of whether the manufacturer, software developer, or vehicle owner is ultimately found liable.

2. No insurance dependency: The lien does not require PIP, MedPay, or health insurance to be active or available. It operates independently of all insurance coverage.

3. Multi-year coverage: Unlike insurance benefits that exhaust, the pharmacy lien continues as long as the patient needs medications and the case is active. There is no annual cap or lifetime limit.

4. Comprehensive documentation: The MERIT report documents every medication dispensed over the entire case timeline — 3, 4, or 5 years of continuous records that demonstrate treatment compliance and medical necessity.

[!TIP] When enrolling an AV accident client in a pharmacy lien program, inform them that the case may take significantly longer than a conventional auto accident to resolve. Set expectations about the extended timeline and explain that the pharmacy lien ensures uninterrupted medication access throughout.

Common AV Accident Injuries and Medication Needs

AV accidents frequently involve unique injury patterns because of the circumstances: the vehicle may fail to brake, accelerate unexpectedly, or navigate into fixed objects or pedestrians. Common injuries include:

Traumatic brain injury (TBI): AV crashes that involve sudden deceleration or impact with the vehicle interior frequently cause TBI. Medications include anti-seizure drugs (levetiracetam, phenytoin), cognitive enhancers (memantine, donepezil), and mood stabilizers.

Spinal cord injuries: High-speed AV crashes can cause spinal fractures and cord compression. Medications include muscle relaxants (baclofen, tizanidine), neuropathic pain agents (gabapentin, pregabalin), and anti-spasticity medications.

Multi-system trauma: Pedestrians and cyclists struck by AVs frequently sustain multi-system injuries requiring complex medication regimens spanning pain management, infection prevention, and rehabilitation support.

As Amar Lunagaria, PharmD, LienScripts' Chief Pharmacist explains, "AV accident injuries tend to be more severe than typical fender-bender cases because the crash circumstances are often high-speed or involve pedestrians. The medication regimens are complex, long-term, and expensive — exactly the profile where pharmacy lien funding is most critical."

Discovery and Documentation Advantages

AV accident litigation involves extensive discovery — including vehicle data logs, software version histories, sensor calibration records, and mapping data. The pharmacy documentation generated by LienScripts during the case adds a critical plaintiff-side evidence stream:

Treatment timeline correlation. The MERIT report's medication timeline can be overlaid with the AV's data logs to show the progression of injury symptoms and treatment needs following the crash.

Continuous treatment compliance. Defense experts in AV cases frequently argue that the plaintiff's injuries were pre-existing or that the plaintiff failed to mitigate damages through non-compliance with treatment. A continuous, multi-year medication record from LienScripts eliminates this argument.

Damages quantification. In a case where liability may ultimately rest with a vehicle manufacturer or technology company, the damages component is critical. A comprehensive pharmacy record with per-medication clinical justification supports a robust damages claim.

[!KEY] AV accident litigation is document-intensive. The MERIT report — covering years of continuous medication dispensing — provides a plaintiff-side documentation asset that is as methodical and detailed as the defendant manufacturer's engineering data logs.

Insurance Coverage Complications in AV Cases

AV accidents create insurance coverage disputes that are unique to the technology:

• Whose auto insurance applies? If the vehicle was in autonomous mode, is the occupant's auto insurance liable, the manufacturer's product liability insurance, or a commercial fleet policy?
• Commercial vs. personal coverage: Many AVs operate as commercial ride-hailing vehicles (Waymo, Cruise). Commercial fleet policies may cover passengers differently than personal auto policies.
• Manufacturer recall and warranty: Some AV manufacturers have voluntarily covered medical expenses for crash victims. This coverage is not guaranteed and can be withdrawn at any time.

These coverage disputes further delay the availability of insurance-funded medication access, reinforcing the pharmacy lien as the most reliable funding mechanism.

Building AV Accident Cases Into Your Practice

PI attorneys who develop expertise in AV accident cases position themselves at the forefront of an emerging and growing practice area. Key steps:

1. Track NHTSA AV crash reports — NHTSA publishes incident reports for AV crashes on public roads
2. Understand the technology — Basic knowledge of lidar, radar, camera-based perception systems, and decision-making algorithms helps in depositions and expert witness selection
3. Build manufacturer-specific knowledge — Each AV manufacturer has different technology, different failure modes, and different litigation history
4. Partner with a pharmacy lien provider that can support multi-year cases — the LienScripts platform has no time limit on lien-funded dispensing

Related Resources

• E-Scooter Accidents and Pharmacy Liens
• Mass Tort Pharmacy Lien Coordination
• What Is a Pharmacy Lien?
• Comparative Fault and Pharmacy Liens